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Renal cell osteopontin production is stimulated by calcium oxalate
monohydrate crystals. Specific anions in tubular fluid, including uropontin(UP), the urinary form of human osteopontin (OPN), block adhesion to
renal tubular cells of the most common crystal in kidney stones, calcium
oxalate monohydrate (COM). In this study, monkey renal epithelial cells
(BSC-1 line) in monolayer culture constitutively secreted UP into the
culture medium. COM crystals added to the medium avidly bound
previously secreted UP, reducing its concentration by 46% one hour later.
However, the net UP content of cultures after a 24-hour exposure to COM
crystals was increased by 18%. Northern blotting showed that the consti-
tutively expressed gene encoding human OPN was maximally stimulated
in BSC-1 cells after exposure to COM crystals for 12 hours. Two other
calcium-containing crystals, hydroxyapatite and brushite, did not alter
OPN gene expression or protein production. OPN mRNA expression was
enhanced in canine renal epithelial cells (MDCK line) after exposure to
COM crystals for six hours, whereas the constitutive expression of murine
OPN mRNA by 3T3 fibroblasts was unchanged. In vivo this glycoprotein
could defend the cell against adhesion of crystals in tubular fluid, and/or
promote renal interstitial fibrosis in subjects with heavy ciystalluria.
Urine is usually supersaturated with calcium and oxalate ions
that nucleate to form calcium oxalate crystals [1]. The fate of
newly-formed crystals in the nephron is not clear. Once formed a
crystal could either grow large enough to occlude the tubule
lumen, aggregate with other crystals to form a mass large enough
to do so, or adhere to the tubular epithelium; otherwise it would
be swept out of the nephron in the flowing fluid within a few
minutes. Although growth, aggregation, and cell adhesion may
contribute to crystal retention in the nephron, cell-crystal inter-
actions have not been as extensively studied as the former two
processes. Crystals of calcium oxalate monohydrate (COM) that
form in tubular fluid can bind to the apical surface of cultured
renal epithelial cells and become internalized [2—51, thereby
stimulating an array of responses including proliferation [6—9].
Cell-crystal interactions in vivo could lead to crystal retention in
the kidney and the development of nephrolithiasis, and/or pro-
mote interstitial fibrosis and scarring in subjects with excessive
crystalluria as occurs in primary hyperoxaluria [8].
We have employed cultures of renal epithelial cells (BSC-i and
MDCK lines) and COM crystals as a model system to study the
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interaction between kidney cells and crystals in tubular fluid; both
cell lines are likely derived from the distal nephron [2, 6—8, 10].
Adhesion of COM crystals to these renal cells is crystal-type
specific and can be blocked by anions found in urine such as
citrate, glycosaminoglycans, and the glycoprotein uropontin (UP)
[2, 11]. The cell-crystal interaction stimulates expression of spe-
cific genes including several that are important for transduction of
a growth response signal (c-myc, EGR-1, NUR-77, c-fun), as well
as others whose protein products could mediate an interstitial
fibrotic response (plasminogen-activator inhibitor-i, platelet-de-
rived growth factor-A chain, and connective tissue growth factor)
[81.
Since the DNA sequence encoding UP is known, we were able
to examine the effects of COM crystals on synthesis of this urinary
anion at both the mRNA and protein levels in renal cells. UP, the
urinary form of human osteopontin (OPN), is an aspartic acid-rich
secreted glycoprotein originally identified as a constituent of bone
matrix [121. UP can regulate the growth of calcium oxalate crystals
[13], presumably by its high density of aspartic acid residues, and
can also mediate cell-cell and cell-matrix adhesion, as well as
signalling [12, 14] by binding to the plasma membrane integrin
avf33 via an Arg-Gly-Asp (RGD) recognition motif [15—171. We
studied gene expression and release of UP following the exposure
of renal epithelial cells to COM crystals to determine the role of
this glycoprotein in cell-crystal interactions.
Methods
Materials
Crystals of COM, hydroxyapatite (HA) or brushite (BR) were
each prepared from supersaturated solutions by Y. Nakagawa
(University of Chicago) as previously described [18]. COM crys-
tals were cuboidal to spindle shaped, and uniformly small at 1 to
2 jim in diameter. HA crystals were 2 to 5 jim in size and nearly
spherical, whereas BR crystals were planar and irregularly shaped
at ito 3 jim in diameter. Latex beads (1.1 jim diameter) (Sigma
Chemical, St. Louis, MO, USA) were used as control particles of
similar size. Crystals were sterilized by heating to 180°C overnight.
X-ray crystallography (performed by S. Deganello, University of
Palermo, Italy) demonstrated that heating did not alter the
structure of COM crystals.
Cell culture
Quiescent cultures of three separate cell lines were prepared
utilizing conditions previously employed [6]. Renal epithelial cells
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of the nontransformed African green monkey line (BSC-1)were
grown in Dulbecco-Vogt modified Eagle's medium containing 25
m glucose (DMEM), 1.6 tM biotin, and 1% calf serum at 38°C
in a CO2 incubator. Under these conditions, BSC-1 cells achieved
confluence at 106 ceils/60 mm plastic dish (Nunc, Naperville, IL,
USA). High-density, quiescent cultures were prepared by plating
2 x 106 cells/dish. The spent medium was changed after three
days so that there were 3 to 4 X 106 cells/plate six days later.
Medium was then aspirated and replaced with fresh medium
containing 16 LM biotin and 0.01% calf serum. Three days later
these high-density, quiescent cultures were used for study.
Madin-Darby canine kidney (MDCK) cells were grown in
DMEM containing 2% calf serum and 1.6 /LM biotin as described
previously [6]. To prepare high-density, quiescent cultures, 2 ><
106 cells/60 mm dish were plated in DMEM containing 2% calf
serum and 1.6 jM biotin. Two days later the medium was
aspirated and replaced with fresh medium containing 0.5% calf
serum and biotin. One day later the cultures were used for study
at a density of 4 X 106 cells/dish.
BALB/c3T3 fibroblasts were grown in DMEM containing 10%
calf serum as described [6]. To prepare high-density, quiescent
cultures, 7 x iO cells were plated per 60 mm dish. Two days later
the medium was aspirated and replaced with fresh medium
containing 1% calf serum and 1.6 1ILM biotin; the cells were used
one day later when a density of 17 x 106 cells/dish was reached.
Quantification of uropontin protein
COM crystals suspended in sterile water were added to the
medium of high-density, quiescent cultures of BSC-1 cells to
achieve a final concentration of 200 g/ml (47.2 ftg/cm2) [6]. At
specified times after addition of crystals, the medium was carefully
aspirated, centrifuged at 3000 X g for five minutes to remove any
unbound crystals, and phenylmethylsuifonyifluoride (PMSF, 0.5
mM) and sodium azide (0.2%) were added to the supernatant.
The portion of UP bound to crystals and/or cells was recovered
by extraction after aspiration of the medium. The monolayer with
its adherent crystals was initially incubated for four hours with 1.0
ml of an extraction buffer (EB: 10 mrvi phosphate, 155 mrvi NaC1,
5.4 mivi KC1, 500 mi EDTA, and 0.1% thimerosal at pH 7.4).
Inspection of cells by light microscopy revealed that all visible
crystals had dissolved under these conditions. Control monolayers
not exposed to crystals were similarly extracted. Cells were then
scraped into a 2 ml microcentrifuge tube along with 0.5 ml of EB
used to wash the culture plate and frozen to —70°C to disrupt the
cells. After thawing, the cell suspension was extracted for an
additional 12 hours in the microcentrifuge tube by vertical circular
rotation at 4°C, After centrifugation at 10,000 RPM in an
Eppendorf microcentrifuge for 10 minutes, the extract was trans-
ferred to another tube prior to immunoassay. An additional
overnight extraction of the cell pellet with 1.5 ml of EB verified
that complete extraction had occurred with the first 1.5 ml of EB.
Net UP production by each culture was determined as the sum of
the amount of UP in the cell-crystal extract (1.5 ml) and in the
previously-collected culture medium (5 ml) as measured by the
enzyme-linked immunoassay (ELISA) described below.
COM, HA or BR crystals, or latex beads (200 ig/ml) were
added directly to conditioned medium (5 ml) obtained from
cultures of BSC-1 cells to assess the capacity of specific crystals to
bind UP. The conditioned medium and the particulate under
study were incubated in fresh 60 m dishes in the absence of cells
at 38°C in a CO2 incubator. At specified times thereafter, the
medium was placed in a 13-mi tube (Sarstadt, NUmbrecht, Ger-
many) and centrifuged at 3000 X g to pellet the crystals. The
supernatant was then carefully aspirated and PMSF (0.5 mM) and
sodium azide (0.2%) were added. Conditioned media, buffers and
cell extracts were stored at 4°C prior to assay for UP.
Our previously described ELISA for uropontin [13] was modi-
fied as follows utilizing monospecific polyclonal antibodies for
detection of UP in cell culture samples. Solutions diluted with
500 mM EDTA buffer, pH 9.3 were used to directly coat 96-well
polyvinyl chloride microtiter plates (Dynatech, Woodbridge, VA,
USA) or polystyrene microtiter plates (Maxisorb, NUNC) for 15
hours at 4°C. The washing buffer contained 0.01 M Tris, 0.154 M
NaC1 and 5 mvi CaC12 at pH 7.6. Blocking buffer was prepared by
addition of bovine serum albumin (10 mg/ml) to the washing
buffer. All immunoassays for UP were performed using a series of
dilutions of a single preparation of affinity-purified UP on each
plate as standards. Concentrations of UP in samples were calcu-
lated using a curve derived from the optical densities of standards
run on the same plate. Assays were performed on coded samples
and were paired for analysis on the same plate on the basis of the
experimental design described below. The lower limit of reliable
detection of UP standards by ELISA was between 2 to 10 ng/ml;
therefore, the lowest level of UP detectable in the experimental
samples was typically 160 ng/ml. To permit statistical analysis for
samples with levels of UP below this level, the detection limit was
applied as the value, recognizing that this would reduce the level
of statistical significance.
Polyclonal antibodies to UP were prepared by immunizing
rabbits with UP isolated by immunoaffinity purification using
monoclonal antibody ZH2 beads as described previously [13].
This antiserum was affinity purified by passage over a urinary
protein fraction coupled to Sepharose 4B® beads. The urinary
protein fraction used for affinity purification was obtained by
batch elution from DEAE-cellulose and depleted of UP by
exposure to ZH2 beads prior to immobilization. This monospe-
cific polyclonal anti-uropontin antiserum (pUP-I) was used in the
studies described below. An affinity-purified peroxidase conju-
gated goat anti-rabbit IgG obtained from Jackson Immuno-
Research (West Grove, PA, USA) was used as the secondary
antibody.
Northern analysis
COM, HA, or BR crystals, or latex beads were each added from
a suspension in sterile water to the media of high-density,
quiescent cultures of BSC-1, MDCK or 3T3 cells to achieve a final
concentration of 200 frg/ml [6]. At specified times thereafter cells
were lysed in guanidinium isothiocyanate, scraped off the dish,
and RNA was extracted as previously described [19]. Aliquots of
total RNA (20 tg) were electrophoresed through a 1.4% aga-
rose-6% formaldehyde gel, and transferred to a nylon membrane
(Nytran; Schleicher & Schuell, Keene, NH, USA). DNA probes
were labeled with [a-32P]dCTP by random hexamer priming [20],
and hybridized to Northern blots at 42°C in a solution containing
1 M NaCI, 1% sodium dodecylsulfate (SDS), 50% formamide, and
10% dextran sulfate [21]. The blots were washed at 65°C in 1 X
SSC buffer (0.3 M NaCI, 0.03 M Na citrate) containing 0,1% SDS.
An autoradiogram of the blot was prepared at —70°C for 24 to 72
hours using X-ray film and two intensifying screens,
The following DNA probes were used for study: human OPN
0.4
0.3
0
0
D
Lieske et al: COM ctystal-stimulated renal cell OPN release 681
Time, hours Time, hours
Fig. 1. UP production by BSC-1 cells and its adhesion to crystals. High-density, quiescent cultures of BSC-1 cells were prepared as described in the
Methods section. A. On day 9 the medium was removed and replaced with fresh DMEM containing 0.01% calf serum. At specified times thereafter,
medium was removed and its UP concentration was assessed by an ELISA. The UP concentration increased from 0.16 0.004 g/ml immediately after
a medium change to a steady state plateau of 0.473 0.046 JLgImI by 24 hours. UP was not detected in DMEM containing 0.01% calf serum prior to
its exposure to cells. B. COM (•), HA (.0.) or BR (--0--) crystals (200 Wml) were added to 3-day conditioned medium in the absence of cells. COM
crystals bound UP, thereby decreasing the baseline concentration of 0.701 0.023 jg/ml to 0.438 0.008 Wml by 30 minutes, and to 0.298 0.017
j.g/ml at three hours. HA crystals (200 jtglml) bound UP more avidly decreasing the concentration to 0.071 0.006 g/ml after five minutes, whereas
BR crystals (200 gIml) did not appear to significantly bind the glycoprotein. Each value is the mean SE for 6 to 12 cultures. #P < 0.05, *p < 0.001
vs. control.
(the full-length 1.278 kb insert in pUC19 obtained from a human
kidney eDNA library by J.R. Hoyer [13] was initially named
nephropontin for GenBank data base accession #M83248, but is
identical to OPN eDNA isolated from bone); mouse OPN (1.1 kb
insert in pGEM4) obtained from D. Denhardt (Rutgers Univer-
sity); rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(1.2 kb insert in pBR322) from M. Favus (University of Chicago).
No less than two blots were prepared and probed with either
human OPN or mouse OPN as indicated, and were subsequently
reprobed with GAPDH to verify that an equal amount of RNA
was loaded in each lane of the gel.
Statistics
Data were compared by Student's I-test. P values less than 0.05
in single comparison were accepted as significant. Values pre-
sented are means SE. When no measures of variances appear, it
is because they are smaller than symbols used for the means.
Results
UP production by renal epithelial cells
Immediately after medium of high-density, quiescent BSC-1
cells was replaced with fresh DMEM containing 0.01% calf serum,
0.16 0.004 jig/mi of UP was detected in it by ELISA (Fig. 1A).
UP was not detected in DMEM containing 0.01% serum prior to
its exposure to cells. The UP content increased to 0.23 0.03
jig/mi at 12 hours after addition of fresh medium (P < 0.05 vs.
time 0), and reached a steady state value of 0.47 0.05 jig/ml by
24 hours (P < 0.001). However, expression of the OPN gene did
not change between 1 and 24 hours after a medium change when
assessed by Northern analysis (data not shown).
To determine if crystals bound UP released by the cells,
medium conditioned by high-density, quiescent cultures for three
days was collected and placed in culture dishes without cells.
Addition of COM crystals (200 jig/mi) to this conditioned me-
dium decreased the concentration of UP from 0.70 0.02 jig/mi
at time 0 to 0.44 0.01 jig/mi after 30 minutes (P < 0.05), and to
0.30 0.02 jig/mi by three hours (P < 0.001; Fig. 1B). HA crystals
(200 jig/mi) appeared to bind UP more avidly than did COM
crystals, decreasing the concentration to 0.07 0.01 jig/mi after
only five minutes (P < 0.001). BR crystals (200 jig/ml) did not
significantly alter the concentration of UP when present up to
three hours (Fig. 1B), nor did latex beads (data not shown). Thus,
each of the calcium-containing urinary crystals studied appeared
to have a different affinity for UP.
Net UP content of cultures was determined by removing
conditioned medium to obtain free UP, and then extracting
monolayers with an EDTA-containing buffer to recover the UP
associated with cells and/or crystals. Total (free plus extracted)
UP content of cultures exposed to COM crystals was greater than
control at 24 hours (Fig. 2A), and remained elevated for up to 36
hours (8.541 0.249 vs. 6.617 0.333 jig/culture; P < 0.001).
However, total UP content of cultures exposed to HA or BR
crystals for 24 hours did not change (Fig. 2B). Extracted UP
contributed only 3.9% of the 24 hour total for control cultures
compared to a much greater fraction for the crystal-exposed cells
(COM 39.7%, HA 81.5%, BR 32.4%). Thus, constitutive UP
production by BSC-1 cells is stimulated by an interaction with
COM crystals for greater than 24 hours, an effect not shared by
two other calcium-containing crystals.
Effect of COM crystals on OPN gene expression in BSC-1 cells
The kinetics of expression of the OPN gene was investigated in
cells exposed to 200 jig/ml of COM crystals, a concentration
previously shown to maximally stimulate DNA synthesis [6]. An
equal volume of the vehicle was added to control cells. The gene
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Fig. 2. Effect of COM, HA and BR c,ystals on
UP production by BSC-1 cells. COM, HA, or
BR crystals (200 jsg/ml), or vehicle were added
to high-density, quiescent cultures of BSC-1
cells. Twelve or 24 hours later conditioned
medium was collected and saved, and the
monolayer and its associated crystals were
extracted with an EDTA-containing buffer as
described in the Methods section. A. When
amounts of UP present in conditioned medium
and in the cell layer following extraction with
EDTA were combined, COM crystals
significantly enhanced UP production by cells at
24 (P < 0.001) but not at 12 hours. B.
Exposure of cells to COM crystals for 24 hours
enhanced UP production (P < 0.001) whereas
neither HA nor BR crystals did so. Each value
is the mean SE for 6 to 9 cultures.l2hr 24 hr
Hours: 1 6 12 24
1.5 kb Uropontiri
1.3kb —
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Fig. 3. Northern blot analysis of total RNA from BSC-1 cells after exposure to COM ciystals. High-density, quiescent cultures of BSC-1 cells were prepared
and COM crystals (200 sgJml) were added for specified periods of time (+). Control cells were prepared at each corresponding time by not adding
crystals (—). Total cellular RNA was extracted and 20 rg was electrophoresed through a 1.4% agarose gel containing formaldehyde, and then
transferred to a Nytran filter. The filter was hybridized with an [cs-32PIcDNA probe for human UP or GAPDH. The transcript for UP was constitutively
expressed; it was maximally stimulated 12 hours after addition of crystals. No change in expression of the gene encoding UP was detected under control
conditions.
encoding UP was constitutively expressed in BSC-1 cells, and was
maximally stimulated 12 hours after exposure to COM crystals
(Fig. 3). Enhanced expression persisted up to 36 hours (data not
shown). In control cells, the level of constitutive expression of
OPN was unchanged during this period (Fig. 3). The mRNA
encoding GAPDH, an enzyme that mediates glycolytic metabo-
lisni, was constitutively expressed and was not altered by addition
of crystals; it served to document equal loading of RNA in
different lanes of Northern blots. In additional experiments, the
medium was aspirated prior to addition of crystals and replaced
with fresh medium containing 16 M biotin and 0.01% calf serum
prior to addition of crystals. As in the absence of a medium
change, Northern analysis revealed constitutive expression of the
OPN gene under control conditions, and maximal stimulation 12
hours after exposure to COM crystals. Due to the near insolubility
of COM crystals (1.5 >< i0° M2 at 37°C, pH 7.4) [1], free Ca2 in
the vehicle (water) is very low (—40 j.LM) so that a relatively
insignificant quantity is added to the culture medium whose
calcium concentration is 1.8 m. Therefore, alteration in the free
Ca2 concentration of the medium is not likely to stimulate OPN
gene expression.
Specificity of OPN gene expression
To determine whether stimulation of OPN gene expression by
COM crystals is cell-type specific, experiments were performed in
cultures of canine renal epithelial cells (MDCK line) and murine
BALB/3T3 fibroblasts. High-density, quiescent MDCK or 3T3
cells were exposed to COM crystals (200 ig/ml) for 1, 6, 12 or 24
hours and expression of the human or mouse OPN gene was
estimated. In MDCK cells, expression of the human OPN gene
was maximally stimulated (2-fold) by COM crystals at six hours
and returned to near the control value by 24 hours, whereas in
BSC-i cells more marked (7-fold) crystal-stimulation of OPN
gene expression was detected between 12 and 24 hours (Fig. 4).
RNA from murine fibroblasts did not hybridize with the human
OPN eDNA probe in the absence or presence of COM crystals.
When the blots were reprobed with mouse OPN eDNA constitu-
tive expression was observed, but was not increased by exposure to
COM crystals (Fig. 4C).
Crystal-type specificity of OPN gene expression in BSC-1 cells
was examined by using two other calcium-containing crystals, HA
or BR, and a non-crystalline particulate, latex beads (200 xgIml).
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Fig. 4. Effect of COM crystals on expression of human UP or mouse OPN
mRNA in (A) BSC-], (B) MDCR or (C) 3T3 cells. High-density, quiescent
cultures of BSC-1, MDCK or 3T3 fibroblastic cells were exposed to COM
crystals (200 jLg/ml) for times specified on the abscissa. Northern blots
were prepared and probed with [u-32P] eDNA encoding UP, OPN or
GAPDH, and autoradiograms were prepared. Values on the ordinate are
the ratio of UP or OPN to GAPDH as determined by laser densitometry
of the Northern blots. COM crystals stimulated OPN gene expression in
BSC-1 cells at 12 to 24 hours (A). In MDCK cells, COM crystals
stimulated the gene maximally at six hours, with expression returning to
baseline by 24 hours (B). Expression of mouse OPN varied little after
exposure of 3T3 fibroblasts to COM crystals (C). Note differences in scales
on ordinates for the different types of cells.
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Fig. 5. Effect of COM, HA or BR crystals, or latex beads on expression of
human UP mRNA. High-density, quiescent cultures of BSC-l cells were
exposed to crystals or latex beads at times specified on the abscissa. Total
RNA was extracted, Northern blots were prepared, and the extent of
hybridization of the human UP [a-°2P] cDNA probe was compared by
laser densitometry. Values on the ordinate are the ratio of UP/GAPDH.
Increased gene expression was detected only in the presence of COM
crystals. COM (•), HA (A), BR (0), latex beads (h).
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encoding human UP is constitutively expressed and is stimulated
by COM crystals between 12 and 24 hours after the crystal-cell
interaction, which precedes increased UP protein release. COM
crystal stimulation of OPN gene expression was relatively specific
for renal epithelial cells as it was observed in BSC-1 and MDCK
cells but not fibroblasts. Enhanced expression of the gene also
appears to be crystal-type specific because COM crystals were
stimulatory whereas other calcium-containing crystals (HA, BR)
and latex beads were not.
UP is the urinary form of OPN [13], a sialic acid-rich protein
initially isolated from bone. This phosphoprotein has several
interesting features including adhesion to a,. integrins [22, 23] by
virtue of an RGD sequence through which OPN promotes cell
attachment and spreading [12], as well as a strong affinity for
calcium phosphate-based bone matrix (hydroxylapatite). OPN has
been variably identified as the tumor promoter-inducible mouse
gene 2ar [24], human bone sialoprotein I [25], rat 44-K bone
phosphoprotein [26], mammalian transformation-associated
phosphoprotein [27, 28], rat pp69 [29], and as early T cell
activation gene 1 (Eta-i) [30]. UP was initially purified from
human urine because of its capacity to inhibit calcium oxalate
crystallization [13]. Since then, expression of UP has been iden-
tified in mouse [311 and rat kidney [32—341 by several investigators.
In the murine kidney, OPN mRNA and protein were detected
only in a subset of nephrons and was localized to the thick
ascending limbs of Henle and distal convoluted tubule. Renal
levels of mRNA and protein were increased in pregnant and
lactating animals, and were markedly enhanced in the glomeruli
of aging mice [31]. In rats, OPN mRNA and protein were
localized to thin descending limbs of Henle and distal collecting
tubules, as well as cells lining the calyceal fornices [32, 34].
Production of OPN has been identified in primary cultures of
When the different crystals or latex beads were added to the cells,
only COM crystals stimulated expression of the gene (Fig. 5).
Thus, both crystal- and cell-type specificity of COM-stimulated
OPN gene expression were displayed by these renal epithelial
cells.
Discussion
The results of this study indicate that BSC-1 cells constitutively
produce and secrete UP into the extracellular fluid where it is
avidly bound by two common urinary crystals, COM and HA, but
not by BR. Exposure of renal epithelial cells to COM crystals
stimulates production of additional UP by 24 hours. The gene
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renal cortical tubular cells [35] and established lines such as
normal rat kidney (NRK) cells [361 and MDCK cells [1 In the
canine cell line, a 20-kDa carboxy-terminal fragment of UP was
secreted into the culture medium [37]. Therefore, OPN is clearly
produced in the kidney, although its function and significance
there remain uncertain.
The mechanisms by which a urinary crystal is retained in the
kidney and then incorporated into a stone are not known.
Calculations based on concentrations of ions in tubular fluid and
the maximal rate of calcium oxalate crystal growth suggest that a
crystal could not reach a size large enough to occlude a tubular
lumen in the time necessary for transit from proximal tubule to
the end of the collecting duct [38], although some assumptions
underlying these conclusions have recently been questioned [39].
Thus, factors that allow microcrystals to anchor to the apical cell
surface and thereby remain bathed in supersaturated tubular fluid
could be important determinants of stone growth. Our previous
studies indicate that a COM crystal in the distal nephron lumen
could interact with anionic sialic acid-containing structures on
apical cell surface microvilli [2, 3, 6, 7, 10]. Work by other
investigators utilizing primary cultures of rat inner medullary
collecting duct cells suggests that COM crystals bind to specific
receptors on the cell surface [4]. The number and character of cell
surface crystal receptors may be influenced by the distribution of
apical and basolateral glycoproteins on the plasma membrane [51.
Sites that bind COM crystals on tubular cells may be only
minimally exposed under normal circumstances, but could in-
crease in number following cellular injury, as has been demon-
strated for denuded rat bladder urothelium [40, 41]. If renal
tubular cells in vivo behave as do renal cells in culture, anchoring
of newly-formed COM crystals to apical microvilli could promote
crystal retention in the kidney either through continued crystal
growth and/or by aggregation of additional crystals. Anionic
molecules in tubular fluid, including specific glycoproteins such as
UP [2], could impede this cascade by coating the crystal and
thereby preventing its adhesion to the cell.
The results of the present study suggest that increased nucle-
ation of COM crystals in the nephron lumen and the ensuing
crystal-cell interactions could up-regulate OPN gene expression
and protein secretion by renal tubular cells. Since UP can block
adhesion of COM crystals to renal epithelial cells [2], increased
production of the glycoprotein and its secretion into the nephron
lumen would decrease adhesion of additional crystals to the cell
surface, thereby protecting the kidney against crystal retention
and eventual nephrolithiasis. It should also be noted that our in
vitro observation of COM crystal-stimulated renal cell UP secre-
tion suggests a mechanism whereby rats with experimentally-
induced hyperoxaluria exhibit increased renal OPN gene and
protein expression [31
Enhanced UP production by renal cells after an interaction with
a COM crystal could have other important biological conse-
quences, especially if UP were released across the basolateral
plasma membrane into the interstitium [12]. A recent report from
this laboratory demonstrated that COM crystals trigger expression
of diverse genes in renal epithelial cells whose protein products
could promote interstitial fibrosis such as plasminogen-activator
inhibitor-I, a regulator of extracellular matrix, and two growth
factors, platelet-derived growth factor-A chain and connective
tissue growth factor [8]. As UP is a chemoattractant for macro-
phages and monocytes that can each release cytokines and growth
factors, increased local release of the glycoprotein could facilitate
a fibrotic process in renal tissue [42, 31. The current study
demonstrates that COM crystals stimulate transcription of the
gene encoding UP, providing additional evidence of the unique
capacity of this crystal to induce or stimulate a diverse class of
genes whose products could mediate the development of intersti-
tial fibrosis. Widespread interstitial scarring is not often observed
in patients with nephrolithiasis. However, it is possible that local
release of mediators favoring fibrosis in the vicinity of a renal
tubular cell with an internalized COM crystal could be an
important early event that mediates anchoring of a stone nidus, an
as yet poorly understood process. Disease states characterized by
heavy calcium oxalate ciystalluria, such as primary [44—46] and
secondary [47, 48] hyperoxaluria, are associated with prominent
interstitial fibrosis and progressive renal failure. In these condi-
tions it is possible that changes in OPN gene expression after cells
interact with COM crystals could play an important pathogenic
role. As noted above, increased OPN gene expression and protein
content have been detected in the distal tubules of rats given
ethylene glycol to induce hyperoxaluria [31.
Renal oxalate retention characteristically occurs as kidney
functional failure progresses [49—53], and interstitial deposits of
calcium oxalate crystals have been observed in the kidneys of
patients with chronic renal insufficiency associated with marked
inflammation and fibrosis [45—48]. Since tubulointerstitial injury
appears to be an important component of the inexorable renal
scarring associated with falling glomerular filtration in patients
with chronic renal insufficiency [54—58], it is tempting to speculate
that increased exposure of renal epithelial cells to calcium oxalate
crystals in such patients stimulates expression of genes such as UP
that could mediate interstitial fibrosis [8]. This hypothesis suggests
a new role for COM crystals in the progression of chronic renal
insufficiency.
It will require additional study to elucidate the mechanisms
whereby COM crystals stimulate OPN gene expression and UP
secretion. This response by renal epithelial cells does not appear
to be based on UP depletion from the extracellular fluid. HA
crystals bind UP even more avidly than do COM crystals, but do
not stimulate expression of the OPN gene. It is likely that several
different cellular mechanisms stimulate the OPN gene in renal
epithelial cells because ethylene glycol-induced hyperoxaluria-
and angiotensin Il-induced interstitial nephritis in rats are each
associated with augmented OPN protein and gene expression [33,
34].
We conclude that COM crystals stimulate OPN gene expression
and protein secretion by renal epithelial cells in culture. In specific
disease states associated with marked calcium oxalate crystalluria,
increased UP release into tubular fluid could oppose adhesion
and retention of crystals, while in the interstitium it could promote
renal fibrosis and scarring.
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